Trusted News Discovery Since 2008
{{/content}}
Astra Zeneca gets nod for anticoagulant drug
Credit: IndiaTimes- Published on January 20, 2024
AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organisation for the import and marketing of Andexanet Alfa. The therapy addresses life-threatening or refractory bleeding associated with the use of Factor Xa (FXa) inhibitors, says a company statement.FXa inhibitors are...
You are here
💡 newsR Knowledge: Other News Mentions
AstraZeneca
British pharmaceutical company
Nearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The..
Credit: IndiaTimes - Published 11 hours ago
UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to..
Credit: IndiaTimes - Published 1 week ago
SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing..
Credit: IndiaTimes - Published 1 week ago